2023 Q2 Form 10-Q Financial Statement

#000161600023000040 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $271.1M $269.0M $210.3M
YoY Change -4.37% 27.87% 139.43%
Cost Of Revenue $116.7M $179.3M $141.6M
YoY Change -34.11% 26.6% 83.7%
Gross Profit $154.3M $89.70M $68.74M
YoY Change 45.23% 30.49% 538.37%
Gross Profit Margin 56.93% 33.35% 32.68%
Selling, General & Admin $85.45M $85.47M $69.27M
YoY Change 2.72% 23.38% 47.07%
% of Gross Profit 55.37% 95.29% 100.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $33.49M $33.69M $30.43M
YoY Change -2.22% 10.71% -7.59%
% of Gross Profit 21.7% 37.56% 44.27%
Operating Expenses $119.3M $119.4M $99.84M
YoY Change 1.6% 19.64% 24.49%
Operating Profit $35.00M $33.76M $17.74M
YoY Change -31.0% 90.32% -145.28%
Interest Expense -$21.65M $22.13M $20.54M
YoY Change -206.37% 7.77% 9.54%
% of Operating Profit -61.86% 65.56% 115.78%
Other Income/Expense, Net $2.362M $1.284M -$777.0K
YoY Change 40.51% -265.25% -769.83%
Pretax Income $16.22M $11.77M -$3.870M
YoY Change -49.4% -404.16% -93.31%
Income Tax $1.803M $5.200M $1.600M
% Of Pretax Income 11.12% 44.18%
Net Earnings $13.72M $6.280M -$5.324M
YoY Change -50.37% -217.96% -90.55%
Net Earnings / Revenue 5.06% 2.33% -2.53%
Basic Earnings Per Share $0.12 $0.06 -$0.05
Diluted Earnings Per Share $0.13 $0.06 -$0.05
COMMON SHARES
Basic Shares Outstanding 109.5M shares 111.5M shares 114.3M shares
Diluted Shares Outstanding 109.5M shares 112.0M shares 114.3M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $255.3M $283.2M $179.1M
YoY Change 14.09% 58.12% -49.5%
Cash & Equivalents $255.3M $283.2M $179.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $33.24M $48.26M $36.24M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $288.5M $331.4M $215.3M
YoY Change 8.63% 53.92% -41.68%
LONG-TERM ASSETS
Property, Plant & Equipment $2.589B $2.597B $2.728B
YoY Change -4.38% -4.8% 6.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $61.02M $58.21M $40.16M
YoY Change 30.07% 44.94% 16.06%
Total Long-Term Assets $2.714B $2.719B $2.825B
YoY Change -3.41% -3.73% 6.45%
TOTAL ASSETS
Total Short-Term Assets $288.5M $331.4M $215.3M
Total Long-Term Assets $2.714B $2.719B $2.825B
Total Assets $3.003B $3.051B $3.040B
YoY Change -2.37% 0.36% 0.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $99.76M $95.98M $92.82M
YoY Change -0.67% 3.41% 50.68%
Accrued Expenses $19.37M $19.63M $20.64M
YoY Change -5.03% -4.89% -13.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $130.2M $126.9M $113.5M
YoY Change 7.78% 11.89% 32.85%
LONG-TERM LIABILITIES
Long-Term Debt $1.400B $1.430B $1.430B
YoY Change -2.09% -0.01% 4.05%
Other Long-Term Liabilities $60.86M $63.57M $58.61M
YoY Change 14.09% 8.46% 17.93%
Total Long-Term Liabilities $1.461B $1.493B $1.488B
YoY Change -1.51% 0.33% 4.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $130.2M $126.9M $113.5M
Total Long-Term Liabilities $1.461B $1.493B $1.488B
Total Liabilities $1.616B $1.620B $1.602B
YoY Change 0.77% 1.15% 6.14%
SHAREHOLDERS EQUITY
Retained Earnings -$625.1M -$628.1M -$661.8M
YoY Change -1.42% -5.1% 16.23%
Common Stock $1.082M $1.107M $1.144M
YoY Change -5.42% -3.23% 0.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.386B $1.410B $1.429B
YoY Change
Total Liabilities & Shareholders Equity $3.003B $3.051B $3.040B
YoY Change -2.37% 0.36% 0.57%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $13.72M $6.280M -$5.324M
YoY Change -50.37% -217.96% -90.55%
Depreciation, Depletion And Amortization $33.49M $33.69M $30.43M
YoY Change -2.22% 10.71% -7.59%
Cash From Operating Activities $70.36M $30.31M $32.57M
YoY Change 6.5% -6.94% -204.53%
INVESTING ACTIVITIES
Capital Expenditures $22.36M $11.63M -$336.0M
YoY Change -255.89% -103.46% 4566.56%
Acquisitions
YoY Change
Other Investing Activities $703.0K $1.071M $34.90M
YoY Change -7.13% -96.93% 4885.71%
Cash From Investing Activities -$21.66M -$10.56M -$301.1M
YoY Change 59.4% -96.49% 4498.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -73.75M -$44.30M -$66.48M
YoY Change 7053.15% -33.36% 3485.54%
NET CHANGE
Cash From Operating Activities 70.36M $30.31M $32.57M
Cash From Investing Activities -21.66M -$10.56M -$301.1M
Cash From Financing Activities -73.75M -$44.30M -$66.48M
Net Change In Cash -25.05M -$24.55M -$335.0M
YoY Change -148.69% -92.67% 746.78%
FREE CASH FLOW
Cash From Operating Activities $70.36M $30.31M $32.57M
Capital Expenditures $22.36M $11.63M -$336.0M
Free Cash Flow $48.00M $18.68M $368.6M
YoY Change -40.31% -94.93% -1638.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001616000
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36594
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Xenia Hotels & Resorts, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0141677
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
200 S. Orange Avenue
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2700
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32801
CY2023Q1 dei City Area Code
CityAreaCode
407
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
246-8100
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q1 dei Trading Symbol
TradingSymbol
XHR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
109486200 shares
CY2023Q1 us-gaap Land
Land
460376000 usd
CY2022Q4 us-gaap Land
Land
460536000 usd
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
3097866000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
3086785000 usd
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3558242000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3547321000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
979373000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
945786000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
2578869000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
2601535000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
283154000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
305103000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
58206000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
60807000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
48255000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
37562000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1108000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1068000 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5019000 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5060000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
77401000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
69988000 usd
CY2023Q1 us-gaap Assets
Assets
3050904000 usd
CY2022Q4 us-gaap Assets
Assets
3080055000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1429516000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1429105000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
95982000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
107097000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
11334000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
11455000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
83200000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
72390000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1620032000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1620047000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110661486 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
110661486 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
112519672 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112519672 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1107000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1126000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2036707000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2063273000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-628060000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-623216000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1409754000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1441183000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
21118000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
18825000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1430872000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1460008000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3050904000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3080055000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
268973000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
210347000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
179276000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
141607000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
33741000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
30565000 usd
CY2023Q1 xhr Real Estate Taxes Personal Property Taxes And Insurance
RealEstateTaxesPersonalPropertyTaxesAndInsurance
12470000 usd
CY2022Q1 xhr Real Estate Taxes Personal Property Taxes And Insurance
RealEstateTaxesPersonalPropertyTaxesAndInsurance
10855000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
710000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
517000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8783000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7611000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-232000 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-175000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1278000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
235212000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
192608000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
33761000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17739000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1284000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-777000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
22134000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
20538000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1140000 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-294000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11771000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3870000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5218000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1607000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6553000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5477000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
273000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-153000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
6280000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5324000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111777894 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114326406 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112037369 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114326406 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6553000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5477000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2517000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1152000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
6553000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1808000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
273000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
264000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6280000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2072000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1460008000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6553000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
26746000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11352000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2667000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
258000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1430872000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1438081000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5477000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2435000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
303000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2517000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1152000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1438405000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6553000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5477000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
33687000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
30429000 usd
CY2023Q1 xhr Noncash Ground Rent And Amortization Of Other Intangibles
NoncashGroundRentAndAmortizationOfOtherIntangibles
54000 usd
CY2022Q1 xhr Noncash Ground Rent And Amortization Of Other Intangibles
NoncashGroundRentAndAmortizationOfOtherIntangibles
136000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1282000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1286000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1140000 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-294000 usd
CY2023Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
0 usd
CY2022Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
994000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2591000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2207000 usd
CY2023Q1 xhr Interest Expense Noncash
InterestExpenseNoncash
-1296000 usd
CY2022Q1 xhr Interest Expense Noncash
InterestExpenseNoncash
-409000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
10693000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
7599000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4127000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5315000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9507000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8234000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
10629000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
9780000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30313000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32572000 usd
CY2023Q1 us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
0 usd
CY2022Q1 us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
328493000 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
11634000 usd
CY2022Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
7499000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
32820000 usd
CY2023Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 usd
CY2022Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
1168000 usd
CY2023Q1 xhr Proceeds From Performance Guaranty Payments
ProceedsFromPerformanceGuarantyPayments
1071000 usd
CY2022Q1 xhr Proceeds From Performance Guaranty Payments
ProceedsFromPerformanceGuarantyPayments
912000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10563000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-301092000 usd
CY2023Q1 xhr Proceeds From Secured Debt Modification
ProceedsFromSecuredDebtModification
440000 usd
CY2022Q1 xhr Proceeds From Secured Debt Modification
ProceedsFromSecuredDebtModification
0 usd
CY2023Q1 xhr Repayments Of Secured Debt Payoffs
RepaymentsOfSecuredDebtPayoffs
99488000 usd
CY2022Q1 xhr Repayments Of Secured Debt Payoffs
RepaymentsOfSecuredDebtPayoffs
65000000 usd
CY2023Q1 xhr Repayments Of Secured Debt Principal Payments
RepaymentsOfSecuredDebtPrincipalPayments
890000 usd
CY2022Q1 xhr Repayments Of Secured Debt Principal Payments
RepaymentsOfSecuredDebtPrincipalPayments
932000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
225000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 usd
CY2023Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
125000000 usd
CY2022Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
5554000 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2023Q1 xhr Payment Of Loan Modification Fees
PaymentOfLoanModificationFees
25000 usd
CY2022Q1 xhr Payment Of Loan Modification Fees
PaymentOfLoanModificationFees
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
26746000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
578000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
490000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11459000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
54000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-44300000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-66476000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24550000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-334996000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
365910000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
554231000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
341360000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219235000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
283154000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
179077000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
58206000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
40158000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
341360000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219235000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
23869000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
21433000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
220000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2263000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2891000 usd
CY2023Q1 xhr Distributions Incurred Not Yet Paid
DistributionsIncurredNotYetPaid
11334000 usd
CY2022Q1 xhr Distributions Incurred Not Yet Paid
DistributionsIncurredNotYetPaid
0 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
Organization<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xenia Hotels &amp; Resorts, Inc. (the "Company" or "Xenia") is a Maryland corporation that invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 lodging markets as well as key leisure destinations in the United States. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company's assets are held by, and all the operations are conducted through, XHR LP (the "Operating Partnership"). XHR GP, Inc. is the sole general partner of XHR LP and is wholly-owned by the Company. As of March 31, 2023, the Company collectively owned 95.9% of the common limited partnership units issued by the Operating Partnership ("Operating Partnership Units"). The remaining 4.1% of the Operating Partnership Units are owned by the other limited partners comprised of certain of our current executive officers and current and prior members of our Board of Directors and includes vested and unvested long-term incentive plan ("LTIP") partnership units. LTIP partnership units may or may not vest based on the passage of time and whether certain market-based performance objectives are met. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xenia operates as a real estate investment trust ("REIT"). To qualify as a REIT, the Company cannot operate or manage its hotels. Therefore, the Operating Partnership and its subsidiaries lease the hotel properties to XHR Holding, Inc. and its subsidiaries (collectively with its subsidiaries, "XHR Holding"), the Company's taxable REIT subsidiary ("TRS"), which engages third-party eligible independent contractors to manage the hotels. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023 and 2022, the Company owned 32 and 34 lodging properties, respectively.</span></div>
CY2023Q1 xhr Number Of Top Lodging Markets For Investing
NumberOfTopLodgingMarketsForInvesting
25 market
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
32 property
CY2022Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
34 property
CY2022Q4 us-gaap Accumulated Amortization Of Debt Issuance Costs Line Of Credit Arrangements
AccumulatedAmortizationOfDebtIssuanceCostsLineOfCreditArrangements
6400000 usd
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reclassifications</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts in these condensed consolidated financial statements have been reclassified to conform to the presentation as of and for the three months ended March 31, 2023.</span></div>
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and revenues and expenses. These estimates are prepared using management's best judgment, after considering past, current and expected future economic conditions. Actual results could differ from these estimates.</span></div>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March 31, 2023, the Company had a geographical concentration of revenues generated from hotels in the Orlando, Florida, Phoenix, Arizona and Houston, Texas markets that exceeded 10% of total revenues for the period then </span></div>ended. For the three months ended March 31, 2022, the Company had a geographical concentration of revenues generated from hotels in the Orlando, Florida, and Phoenix, Arizona markets that exceeded 10% of total revenues for the period then ended. To the extent that there are adverse changes in these markets, or the industry sectors that operate in these markets, our business and operating results could be negatively impacted.
CY2023Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
25000000 usd
CY2022Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
26300000 usd
CY2023Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
9500000 usd
CY2023Q1 us-gaap Debt Issuance Costs Line Of Credit Arrangements Gross
DebtIssuanceCostsLineOfCreditArrangementsGross
9600000 usd
CY2022Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Gross
DebtIssuanceCostsLineOfCreditArrangementsGross
7800000 usd
CY2023Q1 us-gaap Accumulated Amortization Of Debt Issuance Costs Line Of Credit Arrangements
AccumulatedAmortizationOfDebtIssuanceCostsLineOfCreditArrangements
4700000 usd
CY2022Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
10500000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
268973000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
210347000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
15534000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
15883000 usd
CY2023Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0572
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1429516000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1429105000 usd
CY2023Q1 xhr Debt Instrument Carrying Amount And Line Of Credit
DebtInstrumentCarryingAmountAndLineOfCredit
1445000000 usd
CY2022Q4 xhr Debt Instrument Carrying Amount And Line Of Credit
DebtInstrumentCarryingAmountAndLineOfCredit
1445000000 usd
CY2022Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0572
CY2021Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0565
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2417000 usd
CY2023Q1 xhr Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYearWeightedAverageInterestRate
0.0459
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3355000 usd
CY2023Q1 xhr Long Term Debt Maturities Repayments Of Principal In Year One Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearOneWeightedAverageInterestRate
0.0459
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
504284000 usd
CY2023Q1 xhr Long Term Debt Maturities Repayments Of Principal In Year Two Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoWeightedAverageInterestRate
0.0636
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
280071000 usd
CY2023Q1 xhr Long Term Debt Maturities Repayments Of Principal In Year Three Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeWeightedAverageInterestRate
0.0619
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
102053000 usd
CY2023Q1 xhr Long Term Debt Maturities Repayments Of Principal In Year Four Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourWeightedAverageInterestRate
0.0465
CY2023Q1 xhr Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
552870000 usd
CY2023Q1 xhr Long Term Debt Maturities Repayments Of Principal After Year Four Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFourWeightedAverageInterestRate
0.0511
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1445050000 usd
CY2023Q1 xhr Long Term Debt Gross Weighted Average Interest Rate
LongTermDebtGrossWeightedAverageInterestRate
0.0572
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q1 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0659
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
15534000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1429516000 usd
CY2023Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0572
CY2023Q1 xhr Number Of Mortgage Loans Repaid
NumberOfMortgageLoansRepaid
1 loan
CY2023Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
1100000 usd
CY2023Q1 xhr Effective Income Tax Rate Reconciliation At Federal And State Combined Effective Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateCombinedEffectiveRate
0.3104
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5200000 usd
CY2022Q1 xhr Effective Income Tax Rate Reconciliation At Federal And State Combined Effective Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateCombinedEffectiveRate
0.1600
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600000 usd
CY2023Q1 xhr Common Stock Maximum Authorized Pursuant To At The Market Agreements Value
CommonStockMaximumAuthorizedPursuantToAtTheMarketAgreementsValue
200000000 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
0 shares
CY2022Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
0 shares
CY2023Q1 xhr Common Stock Remaining Available Pursuant To At The Market Agreements Value
CommonStockRemainingAvailablePursuantToAtTheMarketAgreementsValue
200000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2023Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-03-31
CY2023Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-04-14
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
6280000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5324000 usd
CY2023Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
67000 usd
CY2022Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
0 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6213000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6213000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5324000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5324000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111777894 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114326406 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
259475 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112037369 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114326406 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
423043 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1945306 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1460319 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
162104 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
2679 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3240842 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
10.14
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
22500000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y14D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P20Y
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0571
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18488000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19628000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
533000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
996000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
1529000 usd
CY2023Q1 xhr Operating Lease Including Available Extension Options Weighted Average Remaining Lease Term
OperatingLeaseIncludingAvailableExtensionOptionsWeightedAverageRemainingLeaseTerm
P56Y
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1606000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2157000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2172000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2188000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2204000 usd
CY2023Q1 xhr Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
24444000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34771000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15143000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19628000 usd

Files In Submission

Name View Source Status
xhr-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001616000-23-000040-index-headers.html Edgar Link pending
0001616000-23-000040-index.html Edgar Link pending
0001616000-23-000040.txt Edgar Link pending
0001616000-23-000040-xbrl.zip Edgar Link pending
exhibit311_2023q1x10q.htm Edgar Link pending
exhibit312_2023q1x10q.htm Edgar Link pending
exhibit321_2023q1x10q.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xhr-20230331.htm Edgar Link pending
xhr-20230331.xsd Edgar Link pending
xhr-20230331_def.xml Edgar Link unprocessable
xhr-20230331_lab.xml Edgar Link unprocessable
xhr-20230331_pre.xml Edgar Link unprocessable
xhr-20230331_htm.xml Edgar Link completed